What is Elekta?
Founded in 1972 and headquartered in Stockholm, Sweden, Elekta is a global leader in providing advanced solutions for the treatment of cancer and brain disorders. The company specializes in radiation therapy, radiosurgery, and related equipment, alongside sophisticated clinical management software. Elekta's commitment to innovation aims to enhance patient outcomes and streamline clinical workflows, positioning it as a critical partner for healthcare providers worldwide seeking to advance their oncology services.
How much funding has Elekta raised?
Elekta has raised a total of $200M across 1 funding round:
Debt
$200M
Debt (2011): $200M, investors not publicly disclosed
What's next for Elekta?
The recent major strategic investment signals Elekta's readiness for its next phase of growth and development. This capital infusion is likely to fuel further research and development into cutting-edge treatment modalities, expand its global market reach, and enhance its digital health offerings. Elekta's focus on enterprise-level solutions suggests a strategic direction towards larger healthcare systems and integrated cancer care networks, aiming to solidify its leadership in the fight against cancer.
See full Elekta company page
